Category Biology/Biotechnology

Scientists at the Babraham Institute have shown that two RNA binding proteins hold the key to a stronger immune response to influenza in mice. Their findings, published today in Nature Communications, reveal that the absence of these proteins changes the potency of T cells that arise at the start on an infection. Further research could lead to implications for therapies that harness the immune system, and for vaccine design.

Researchers from the Turner lab focussed on the activity of the RNA binding proteins ZFP36 and ZFP36L1. By studying mice lacking these RNA binding proteins, the researchers were able to show that their absence in T cells during the initial phase of a viral infection leads to a superior cytotoxic immune response.

When the researchers infected mice with influe...

Research findings may help identify drug targets for neuromuscular disorders. Using genetic approaches, researchers have demonstrated how a certain protein is involved in skeletal muscle growth. The findings open new avenues to develop drug targets for neuromuscular diseases and other pathological conditions.

In the gym, you are not just pumping iron, you are oxygenating muscle cells which keeps those muscles healthy, strong and growing — a process called hypertrophy, or an increase in muscle mass due to an increase in muscle cell size. Conversely, under the covers, lounging, your muscles may begin to atrophy, or shrink.

A research team from Chemnitz and Dresden has taken a major step forward in the development of sensitive electronic skin (e-skin) with integrated artificial hairs. E-skins are flexible electronic systems that try to mimic the sensitivity of their natural human skin counterparts. Applications range from skin replacement and medical sensors on the body to artificial skin for humanoid robots and androids. Tiny surface hairs can perceive and anticipate the slightest tactile sensation on human skin and even recognize the direction of touch...

A new study led by Imperial College London finds that drug-resistant mould is spreading from the environment and infecting susceptible people’s lungs.

The researchers found six cases of people infected with a drug-resistant form of a fungi called Aspergillus fumigatus that could be traced back to spores in the environment. Their findings use samples from England, Wales, Scotland and Ireland, and are published in Nature Microbiology.

Aspergillus fumigatus is an environmental mould that can cause fungal lung disease. While people with healthy lungs clear inhaled spores, people with lung conditions or weakened immune systems sometimes cannot, meaning the spores may remain in the lungs causing an infection called aspergillosis. Aspergillosis affects 10-20 million people worldwide...